185 related articles for article (PubMed ID: 24160181)
41. Ligands specify estrogen receptor alpha nuclear localization and degradation.
Kocanova S; Mazaheri M; Caze-Subra S; Bystricky K
BMC Cell Biol; 2010 Dec; 11():98. PubMed ID: 21143970
[TBL] [Abstract][Full Text] [Related]
42. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
[TBL] [Abstract][Full Text] [Related]
43. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis.
Moldogazieva NT; Ostroverkhova DS; Kuzmich NN; Kadochnikov VV; Terentiev AA; Porozov YB
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019136
[TBL] [Abstract][Full Text] [Related]
44. Functional characterization of estrogen receptor subtypes, ERalpha and ERbeta, mediating vitellogenin production in the liver of rainbow trout.
Leaños-Castañeda O; Van Der Kraak G
Toxicol Appl Pharmacol; 2007 Oct; 224(2):116-25. PubMed ID: 17662327
[TBL] [Abstract][Full Text] [Related]
45. ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays.
Leclercq G; Laïos I; Elie-Caille C; Leiber D; Laurent G; Lesniewska E; Tanfin Z; Jacquot Y
J Recept Signal Transduct Res; 2017 Apr; 37(2):149-166. PubMed ID: 27400858
[TBL] [Abstract][Full Text] [Related]
46. Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay.
Arao Y; Korach KS
J Vis Exp; 2018 Dec; (142):. PubMed ID: 30614492
[TBL] [Abstract][Full Text] [Related]
47. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
48. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
Aliau S; Mattras H; Richard E; Borgna JL
Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957
[TBL] [Abstract][Full Text] [Related]
49. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor-dependent mechanisms.
Winuthayanon W; Piyachaturawat P; Suksamrarn A; Ponglikitmongkol M; Arao Y; Hewitt SC; Korach KS
Environ Health Perspect; 2009 Jul; 117(7):1155-61. PubMed ID: 19654927
[TBL] [Abstract][Full Text] [Related]
50. Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein.
Zhao C; Abrams J; Skafar DF
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):1-11. PubMed ID: 16191480
[TBL] [Abstract][Full Text] [Related]
51. Interaction of Coumarin Phytoestrogens with ER
Wang T; Wang Y; Zhuang X; Luan F; Zhao C; Cordeiro MNDS
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150902
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.
Paulmurugan R; Tamrazi A; Massoud TF; Katzenellenbogen JA; Gambhir SS
Mol Endocrinol; 2011 Dec; 25(12):2029-40. PubMed ID: 22052998
[TBL] [Abstract][Full Text] [Related]
53. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.
Movérare-Skrtic S; Börjesson AE; Farman HH; Sjögren K; Windahl SH; Lagerquist MK; Andersson A; Stubelius A; Carlsten H; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1180-5. PubMed ID: 24395795
[TBL] [Abstract][Full Text] [Related]
54. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
55. Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activity.
Kikegawa M; Nakajima A; Yu J; Asai M; Uesawa Y; Sone H
Gene; 2022 Mar; 813():146108. PubMed ID: 34929341
[TBL] [Abstract][Full Text] [Related]
56. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
57. Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.
Sengupta S; Obiorah I; Maximov PY; Curpan R; Jordan VC
Br J Pharmacol; 2013 May; 169(1):167-78. PubMed ID: 23373633
[TBL] [Abstract][Full Text] [Related]
58. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
Arao Y; Korach KS
J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
[TBL] [Abstract][Full Text] [Related]
59. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
Priyanka HP; Krishnan HC; Singh RV; Hima L; Thyagarajan S
Mol Immunol; 2013 Dec; 56(4):328-39. PubMed ID: 23911387
[TBL] [Abstract][Full Text] [Related]
60. Interactions of synthetic estrogens with human estrogen receptors.
Nikov GN; Eshete M; Rajnarayanan RV; Alworth WL
J Endocrinol; 2001 Jul; 170(1):137-45. PubMed ID: 11431146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
